Setting the Scene and Posing Some Questions Dr. Maeve Murray, Senior Clinical Psychologist Cheeverstown Friday 1 st of July 2016.

Slides:



Advertisements
Similar presentations
APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Advertisements

Health Inequalities and Social Care. This morning o What do we know about: o The scale and nature of the health inequalities experienced by people with.
Level Health Equally Well Key findings from a literature review informing collaborative efforts to improve the physical health outcomes of people with.
Making a difference together: Understanding dementia
Screening, Assessment, Diagnosis Treatment and Support for People with Intellectual Disability with Dementia Through a Memory Clinic Model Mary McCarron.
DEMENTIA Presented By Andrea Rose Cadiz Health and Nutrition.
Centre for Research in Geriatric Medicine T HE K NOWLEDGE T RANSLATION P ATHWAY FOR TIMELY D IAGNOSIS OF D EMENTIA Catherine Travers.
The National Task Group Early Detection Screen for Dementia
Dementia in People with a Learning Disability A Care Pathway Using a Collaborative Approach ANDREW GRIFFITHS.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
A National Dementia Strategy for Ireland: Signposting the Possibilities A Clinician’s Perspective Dr. Henry O’Connell Consultant Psychiatrist in Psychiatry.
Leslie Udell Program Co-ordinator Winnserv Inc.
AUTISTIC SPECTRUM DISORDERS Kate Morton. “Usually people look at you when they’re talking to you. I know that they’re working out what I’m thinking, but.
ALZHEIMER’S DISEASE BY JOSEPH MOLLUSO.
Alzheimer’s Disease Tessa Dillon Nova Southeastern University Clinical Genetics Teri Doolittle, PA-C, MHP, DHSc August 3, 2008.
AIM OF POSTER To outline the progress of the Palliative Care for All programme and outline the changes that have taken place with regard to service developments,
Down syndrome and Alzheimer’s disease: A retrospective medical records review Erin Klonoski LEND Fellow MPH Candidate April 30 th, 2010.
500,000 Canadians 71,000+ under the age of 65 72% women Dementia in Canada.
Introduction: Medical Psychology and Border Areas
Laurence Lacoste Ph. D, Paris, France 1*. Introduction : Why ?  Population’s Ageing is a Public Health issue and dementia for the Elderly a reality 
1 From Cause to Movement Shaping a World Without Alzheimer’s Through Advocacy, Volunteerism, Referral and Science Ian Kremer, Esq. Advocacy & Outreach.
1 Supporting people living with dementia and serious sight loss. Catherine Dennison - Thomas Pocklington Trust Rebecca Sheehy - RNIB Mr Paul G Ursell MBBS.
Health Challenge John Greensill. Current arrangements A fully integrated Health and Social Care Service funded 50:50 by NHS Walsall and Walsall Council.
Alzheimer Scotland Dementia Post Diagnostic Support Service Edinburgh January 2014.
Dementia: Alzheimer’s Disease Cyril Evbuomwan Patient Group Meeting 1 st December 2015.
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
KEVIN W. POWERS, Ph.D. CREIGHTON UNIVERSITY ACADEMIC SUCCESS PSYCHOLOGIST CENTER FOR HEALTH AND COUNSELING Student Assessment & The ADA.
BY: AMAN SINGH AND ALLY MATTINGLY Alzheimer's Disease.
COGNITIVE DEVELOPMENT IN LATE ADULTHOOD CHAPTER 18 Lecture Prepared by: Dr. M. Sawhney.
Daniel Marsden - Community Learning Disability Nurse Fat Chance? Opportunities to change for people with learning disabilities. Daniel Marsden – Community.
The arts and dementia innovative ways of living well Maria Parsons Director ARTZ UK.
A tool for NHS Health Check trainers
KAREN BAILEY, KINGS COLLEGE LONDON NATIONAL ADDICTION CENTRE
Introduction to Dementia
Center for Excellence in Aging & Community Wellness
Produced by Wessex LMCs
Dementia Risk Reduction Melanie Earlam PHE 27th September 2016
DEMENTIA Shenae Whitfield & Kate Maddock.
Ethical Issues of Artificial Hydration and Nutrition
Inclusive Community Choices
Changes to Medicaid Coverage of ASD
Pediatric Psychology: An Overview
Delirium: Ethical Considerations
Changing demographics and the impact on dementia
Substance Use Disorders in People Living with HIV
Dr Pattni GP Registrar Church End Medical Centre
Common Headaches in Children: What NPs Should Know
Intellectual Disabilities and Dementia
Cognitive Disorders and Aging
Behavioral Health Overview
Colin Sloane - Quality Improvement Lead Yorkshire and the Humber
Living well with dementia
Department of Psychological Medicine
ALZHEIMER’S ORGANISATIONS AGENTS OF CHANGE
Treatment of Clients Experiencing Anxiety
Early Cognitive Decline and the Aging Brain - Overview
New FDA Guidance on Early Alzheimer’s Disease
Mental health services for people with intellectual disability in the UK Dr Bhathika Perera Consultant Psychiatrist in Intellectual disability Haringey-
Hearing Assessment Options in the UK
Old Age Psychiatry Training Day Overview and objectives
Does Multilingualism Protect Against Alzheimer’s Disease
Presentation 7: Concepts of ill health
Alzheimer's.
Our Commitments for Dementia in Sheffield: have your say
A tool for NHS Health Check trainers (Updated April 2019)
Treating Anxiety From an Integrated Approach
Interreg-IPA Cross-border Cooperation Programme Romania-Serbia
Mental Health and wellbeing
Driving Miss Daisy conference 2017
Learning Disability What does it mean?
Presentation transcript:

Setting the Scene and Posing Some Questions Dr. Maeve Murray, Senior Clinical Psychologist Cheeverstown Friday 1 st of July 2016

Overview Setting the Scene:  Prevalence of Dementia and ID  Posing Some Questions  What ethical considerations are there in prospective assessment?  What is truly informed consent?  When do we discuss diagnosis?  What are the challenges in assessment?  Who is best placed to do these assessments?  What does the National Dementia Strategy tell us?  Is prevention part of our role? References

Dementia and ID People with ID are living longer due to advances in medical care and living circumstances. In 2009 in Ireland there were 3,154 people with Intellectual Disability over the age of 55 & 10,725 over the age of 35 years. 41.1% of the total ID population was over the age of 35 (College of Psychiatrists of Ireland, 2014). Research suggests that people with ID are five times more likely to develop dementia and tend to do so at a younger age when compared with the general population (BPS, 2015; Burke, McCallion, & McCarron 2014; McCarron & Reilly, 2010; O’Caoimhe, Clune & Molloy, 2013).

Dementia and DS People with DS have an even greater risk and present with dementia at a younger age (BPS, 2015; McCarron & Reilly, 2010). People with Down syndrome also have an increased risk of dementia with 15 to 40% lifetime prevalence. This is due to the possession of a triple copy of Chromosome 21 (College of Psychiatrists of Ireland, 2014). 700 people with AD and DS (2013).

Ethicical Considerations with Prospective Assessment Sims (2002) prospective assessment involves administering baseline assessment of social and cognitive functioning before symptoms of dementia occur. Further assessment then at regular intervals. Andermann et al., (2008) WHO criteria for screening

Informed Consent- Option 1 1.Inform people that they are at risk on the basis that it is their right to know. For example, Coventry PCT produced this information leaflet:

Pros 1)It’s overt 2)Normalisation (would people in the general population only be screened for dementia if they decided they wanted to be?) Cons 1)Assessment and eventual diagnosis if it does occur takes several years – it may be very confusing to be told about something that may/may not develop for several years. 2)Anxiety provoking 3)Is it truly informed consent?

Informed Consent-Option 2 2. Seek consent for assessment but do not specifically mention dementia, for example:

Pros 1)Less anxiety provoking 2)Allows for alternative explanations to assessment results if a decline in functioning is found (e.g. physical health problem, mental health problem, mild cognitive impairment rather than dementia). 3)Is it giving information in a way people can process (not too much too soon)? Cons 1)Less overt, less clear?

Timing of discussion about dementia. Disclosure about diagnosis of dementia needs to be person-centred (do they want to know?). Cahill & Pierce (2013), benefits of sharing a diagnosis and practices in Ireland with general population. Discussion about Diagnosis

Challenges to Assessment Communication difficulties Reliance on collateral information Staff turnover Subjectivity Diagnostic Overshadowing

Who is Best Placed to Assess? Disability ServicesMainstream Services

National Dementia Strategy

Is prevention part of our role? Advocating for people with ID in relation to their access to factors that decrease the likelihood of onset and/or slow the progression of dementia (see Prof. Robertson’s presentation at Genio conference): – More time spent in education – Cognitively stimulating environments – Individual as opposed to congregate living environments – Empowerment (Healthy diet, regular exercise etc.)

References Andermann, A, Blancquaert, I.,, Beauchamp, S., Déry, V., (2008). Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bulletin of the World Health Organisation 86(4): Accessed from /en/ /en/ British Psychological Society (BPS; 2015). Dementia and People with Intellectual Disabilities: Guidance on the Assessment, Diagnosis, Interventions and Support of People with Intellectual Disabilities who Develop Dementia. Burke, E., McCallion, P., & McCarron, M. (2014). Advancing Years, Different Challenges: Wave 2 IDS-TILDA: Findings on the Ageing of People with an Intellectual Disability. Available from: Cahill S. & Pierce, M. (2013). Briefing Paper on Dementia Diagnosis.Genio College of Psychiatrists of Ireland (2014). A Guidance Document on Dementia in Persons with Intellectual Disability Hollins, S., Attard, M.T., von Fraunhofer, N., McGuigan, S, & Sedgwick, P. (1998). Mortality in people with learning disability: Risks, causes, and death certification findings in London. Developmental Medicine and Child Neurology 40:50-56.

References McCarron, M. & Reilly, E. (2010). Supporting Persons with Intellectual Disability and Dementia: Quality Dementia Care Standards: A Guide to Practice. Daughters of Charity Service. Trinity College, Dublin. Intellectual-Disability.pdf Intellectual-Disability.pdf O’Caoimh, R., Clune, Y., & Molloy, D.M. (2013). Screening for Alzheimer’s Disease in Downs Syndrome. Journal of Alzheimer’s Disease and Parkinsonism S7:001. Robertson, I. (2015). The Brain and Environment. conference-2015/podcast-the-brain-and-environment conference-2015/podcast-the-brain-and-environment Sims, J. (2002). The Ethics of Prospective Assessment for Dementia in People with Down’s Syndrome. Clinical Psychology 13: The Alzheimer’s Society of Ireland (2015). A Short Guide to the National Dementia Strategy. ASI-NDS-4-Page-A4-(Feb-2015)-Web_3.pdf ASI-NDS-4-Page-A4-(Feb-2015)-Web_3.pdf

Thank you for listening